Charity Scripture - 15 Aug 2022 Form 4 Insider Report for BELLICUM PHARMACEUTICALS, INC

Role
Chief Development Officer
Signature
Charity Scripture
Issuer symbol
N/A
Transactions as of
15 Aug 2022
Net transactions value
+$360,000
Form type
4
Filing time
16 Aug 2022, 17:04:47 UTC
Previous filing
02 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLCM Stock Option (right to buy) Award $360,000 +250,000 $1.44 250,000 15 Aug 2022 Common Stock 250,000 $1.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third (1/3rd) of the shares subject to the option will vest on the one-year anniversary on August 15, 2023, and the remaining shares will vest in twenty-four (24) equal monthly installments thereafter.